4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-23-070013
Options or other derivatives
- Chief Executive Officer acquired 590,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kirn David Chief Executive Officer | 2023-12-11 | Grant or award · Stock Option (Right to Buy) | +590,000 | 590,000 | D | ||
Loading xslF345X05/ownership.xml…